Female hair loss

Abstract

Hair loss in female patients is a distressing condition. Patients can present to GPs for assessment, advice and consideration of onward referral. A wide range of disorders can lead to hair loss in females. This article will outline common disorders and their clinical features, including investigation and management strategies for primary and secondary care. A sound understanding of the course and prognosis of diseases allows open discussion with patients during healthcare consultations, and is important given the distressing nature of hair loss.

Get full access to this article

View all access options for this article.

References

Aguado Lobo

Jiménez-Reyes

(2018) Traction alopecia. International Journal of Dermatology 57(2): 231–7. DOI: 10.1111/ijd.13846.

Alzolibani

Kang

Otberg

et al.(2008) Pseudopelade of Brocq. Dermatologic Therapy 21(4): 257–63. DOI: 10.1111/j.1529-8019.2008.00207.

Badaoui

Reygagne

Cavelier-Balloy

et al.(2016) Dissecting cellulitis of the scalp: A retrospective study of 51 patients and review of literature. British Journal Dermatology 174(2): 421–423. DOI: 10.1111/bjd.13999.

Blume-Peytavi

Hillmann

Dietz

et al.(2011) A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. Journal of the American Academy of Dermatology 65(6): 1126–1134. DOI: 10.1016/j.jaad.2010.09.724.

Blumeyer

Tosti

Messenger

et al.(2011) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. European Dermatology Forum (EDF). Journal of the German Society of Dermatology Supplement 6: S1–57. DOI: 10.13188/2373-1044.1000046.

Bolduc

Sperling

Shapiro

(2016) Primary cicatricial alopecia: Other lymphocytic primary cicatricial alopecias and neutrophilic and mixed primary cicatricial alopecias. Journal of the American Academy Dermatology 75(6): 1101–1117. DOI: 10.1016/j.jaad.2015.01.056.

British Association of Dermatologist (2012) Patient information leaflet: Androgenic alopecia. Available at: www.bad.org.uk/shared/get-file.ashx?id=3830&itemtype=document (accessed 28 January 2019).

British Association of Dermatologist (2013) Patient information leaflet: Telogen effluvium. Available at: www.bad.org.uk/shared/get-file.ashx?id=132&itemtype=document (accessed 28 January 2019).

British Association of Dermatologist (2015a) Patient information leaflet: Frontal fibrosing alopecia. Available at: www.bad.org.uk/shared/get-file.ashx?id=3454&itemtype=document (accessed 28 January 2019).

10.

British Association of Dermatologist (2015b) Patient information leaflet: Folliculitis decalvans. Available at: www.bad.org.uk/shared/get-file.ashx?id=165&itemtype=document (accessed 28 January 2019).

11.

British Association of Dermatologist (2016) Patient information leaflet: Lichen planopilaris. Available at: www.bad.org.uk/shared/get-file.ashx?id=97&itemtype=document (accessed 28 January 2019).

12.

British Association of Dermatologist (2017) Patient information leaflet: Alopecia areata. Available at: www.bad.org.uk/shared/get-file.ashx?id=68&itemtype=document (accessed 28 January 2019).

13.

Burkhart

(1980) Beau’s lines. An association with pustular psoriasis and telogen effluvium. Archives of Dermatology 116(10): 190–191. DOI: 10.1001/archderm.1980.01640340100028.

14.

Cevasco

Bergfeld

Remzi

et al.(2007) A case-series of 29 patients with lichen planopilaris: The Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. Journal of the American Academy of Dermatology 57(1): 47–53. DOI: 10.1016/j.jaad.2007.01.011.

15.

Chong

Song

Olsen

(2012) Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus. British Journal of Dermatology 166(1): 29–35. DOI: 10.1111/j.1365-2133.2011.10610.

16.

Crispin

Craiglow

et al.(2016) Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. Journal of Clinical Investigation Insight 1(15): 1–10. DOI: 10.1172/jci.insight.89776.

17.

DermNetNZ (2014) Scalp folliculitis. Available at: www.dermnetnz.org/topics/scalp-folliculitis/ (accessed 14 February 2019).

18.

DermNetNZ (2016) Trichotillomania. Available at: www.dermnetnz.org/topics/trichotillomania/ (accessed 14 February 2019).

19.

Iorizzo M and Tosti A (2019) Frontal fibrosing alopecia: An update on pathogenesis, diagnosis, and treatment. American Journal of Clinical Dermatology 20(3): 379–390. DOI: 10.1007/s40257-019-00424-y.

20.

Jones

Keuthen

Greenberg

(2018) Assessment and treatment of trichotillomania (hair pulling disorder) and excoriation (skin picking) disorder. Clinics in Dermatology 36(6): 728–736. DOI: 10.1016/j.clindermatol.2018.08.008.

21.

Kassim

Shipman

Szczecinska

et al.(2014) How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A critically appraised topic. British Journal of Dermatology 170(4): 766–771. DOI: 10.1111/bjd.12863.

22.

Mesinkovska

Tellez

Dawes

et al.(2015) The use of oral pioglitazone in the treatment of lichen planopilaris. Journal of the American Academy of Dermatology 72(2): 355–356. DOI: 10.1016/j.jaad.2014.10.036.

23.

Messenger

McKillop

Farrant

et al.(2012) British Association of Dermatologists' guidelines for the management of alopecia areata 2012. British Journal of Dermatology 166: 916–926. DOI: 10.1111/j 1365-2133.2012.10955.

24.

Navarini

Trüeb

(2010) 3 cases of dissecting cellulitis of the scalp treated with adalimumab: Control of inflammation within residual structural disease. Archives in Dermatology 146(5): 517–520. DOI: 10.1001/archdermatol.2010.16.

25.

Park

Khan

Rawnsley

(2018) Hair biology: Growth and pigmentation. Facial Plastic Surgery Clinics of North America 26(4): 415–424.

26.

Sadlier

Kirby

Lally

(2012) Mycophenolate mofetil and hydroxychloroquine: An effective treatment for recalcitrant cutaneous lupus erythematosus. Journal of the American Academy of Dermatology 66: 160–161. DOI: 10.1016/j.jaad.2011.08.036.

27.

Tosti

Iorizzo

Botta

et al.(2006) Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: A randomized, double-blind placebo-controlled trial. Journal of the European Academy Dermatology and Venereology 20: 1243–1247. DOI: 10.1111/j.1468-3083.2006.01781.

28.

Van Zuuren

Fedorowicz

Schoones

(2016) Interventions for female pattern hair loss. Cochrane Database of Systematic Reviews 5: art. no.: CD007628 DOI: 10.1002/14651858.cd007628.pub4.

29.

Wenzel

Brahler

Bauer

et al.(2005) Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: Results of a retrospective study in 43 patients. British Journal Dermatology 153: 157–162. DOI: 10.1111/j.1365-2133.2005.06552.